These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 12190153)

  • 1. The epidemiology of irritable bowel syndrome in North America: a systematic review.
    Saito YA; Schoenfeld P; Locke GR
    Am J Gastroenterol; 2002 Aug; 97(8):1910-5. PubMed ID: 12190153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of constipation in North America: a systematic review.
    Higgins PD; Johanson JF
    Am J Gastroenterol; 2004 Apr; 99(4):750-9. PubMed ID: 15089911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
    Mearin F; Badía X; Balboa A; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Scand J Gastroenterol; 2001 Nov; 36(11):1155-61. PubMed ID: 11686214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological aspects of irritable bowel syndrome in Europe and North America.
    Müller-Lissner SA; Bollani S; Brummer RJ; Coremans G; Dapoigny M; Marshall JK; Muris JW; Oberndorff-Klein Wolthuis A; Pace F; Rodrigo L; Stockbrügger R; Vatn MH
    Digestion; 2001; 64(3):200-4. PubMed ID: 11786669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
    Bommelaer G; Dorval E; Denis P; Czernichow P; Frexinos J; Pelc A; Slama A; El Hasnaoui A
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.
    Saito YA; Locke GR; Talley NJ; Zinsmeister AR; Fett SL; Melton LJ
    Am J Gastroenterol; 2000 Oct; 95(10):2816-24. PubMed ID: 11051354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
    Boyce PM; Koloski NA; Talley NJ
    Am J Gastroenterol; 2000 Nov; 95(11):3176-83. PubMed ID: 11095338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The irritable bowel syndrome and psychiatric disorders in the community: is there a link?
    Talley NJ; Howell S; Poulton R
    Am J Gastroenterol; 2001 Apr; 96(4):1072-9. PubMed ID: 11316149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.
    Lovell RM; Ford AC
    Am J Gastroenterol; 2012 Jul; 107(7):991-1000. PubMed ID: 22613905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The epidemiology of irritable bowel syndrome and functional constipation of Guangzhou residents].
    Wei X; Chen M; Wang J
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):517-20. PubMed ID: 11718050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.
    Okhuysen PC; Jiang ZD; Carlin L; Forbes C; DuPont HL
    Am J Gastroenterol; 2004 Sep; 99(9):1774-8. PubMed ID: 15330917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Chin Med J (Engl); 2000 Jan; 113(1):35-9. PubMed ID: 11775207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life.
    El-Serag HB
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S3-11. PubMed ID: 12775997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.
    Stewart WF; Liberman JN; Sandler RS; Woods MS; Stemhagen A; Chee E; Lipton RB; Farup CE
    Am J Gastroenterol; 1999 Dec; 94(12):3530-40. PubMed ID: 10606315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people.
    Camilleri M; Lee JS; Viramontes B; Bharucha AE; Tangalos EG
    J Am Geriatr Soc; 2000 Sep; 48(9):1142-50. PubMed ID: 10983917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors.
    Kay L; Jørgensen T; Jensen KH
    J Intern Med; 1994 Jul; 236(1):23-30. PubMed ID: 8021568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current prevalence of irritable bowel syndrome in Asia.
    Chang FY; Lu CL; Chen TS
    J Neurogastroenterol Motil; 2010 Oct; 16(4):389-400. PubMed ID: 21103420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in irritable bowel symptoms.
    Thompson WG
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):299-302. PubMed ID: 9096434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking in Irritable Bowel Syndrome: A Systematic Review.
    Sirri L; Grandi S; Tossani E
    J Dual Diagn; 2017; 13(3):184-200. PubMed ID: 28609199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior.
    Masud MA; Hasan M; Khan AK
    Am J Gastroenterol; 2001 May; 96(5):1547-52. PubMed ID: 11374697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.